Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards targeting the breast cancer immune microenvironment
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer
Rui Dong, Jing Wang, Ruilei Guan, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 104-104
Open Access | Times Cited: 2
Deep-Red and Ultrafast Photocatalytic Proximity Labeling Empowered In Situ Dissection of Tumor-Immune Interactions in Primary Tissues
Zhizheng Lou, Yan Zhang, Xuan Liang, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
TPD52 as a Therapeutic Target Identified by Machine Learning Shapes the Immune Microenvironment in Breast Cancer
Jie Xia, Xudong Zhou
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
Complex rearrangements fuel ER+ and HER2+ breast tumours
Kathleen E. Houlahan, Lise Mangiante, Cristina Sotomayor-Vivas, et al.
Nature (2025)
Open Access
Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers
Femke A. I. Ehlers, Katie E. Blise, Courtney B. Betts, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Paradoxical control of multifocal mammary oncogenesis by radiation therapy
Lorenzo Galluzzi, Aitziber Buqué
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and bulk RNA-seq
Yulin Shi, Yang Yu, J. Zhao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Cryo‐Shocked Tumor‐Reprogrammed Sonosensitive Antigen‐Presenting Cells Improving Sonoimmunotherapy via T Cells and NK Cells Immunity
Xindi Qian, Wenzhe Yi, Wenlu Yan, et al.
Advanced Materials (2025)
Closed Access
CD44-targeting and ZIF-8-gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death
Xin Li, Fei Xiong, Xudong Cao, et al.
Chinese Chemical Letters (2025), pp. 110970-110970
Closed Access
Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation
Huiyuan Yang, Tingting Sun, Zhenni Sun, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Comprehensive analysis of lipid metabolic signatures identified CEBPD promotes breast cancer cell proliferation
Yu Zhao, Huan He, Linyan Huang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Role of circular RNAs in cancer therapy resistance
Wenjuan Liu, Jiling Niu, Yanfei Huo, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
Tânia Moura, Paula Laranjeira, Olga Caramelo, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 143-143
Open Access
Association between cancer-associated fibroblasts and prognosis of neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a bioinformatics analysis based on single-cell RNA sequencing
Zhao Huang, Zhuang‐Zhuang Cong, Jing Luo, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Tumor-derived extracellular vesicles: key drivers of immunomodulation in breast cancer
Jieming Li, Shuo Yu, Min Rao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Integrating spatial and single-cell transcriptomes reveals the role of COL1A2(+) MMP1(+/-) cancer-associated fibroblasts in ER-positive breast cancer
Zhihao Yu, Haonan Xu, Shuo Wang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113601-113601
Closed Access
Population-specific patterns in assessing molecular subtypes of young black females with triple-negative breast cancer
Padma Sheila Rajagopal, Sonya Reid, Run Fan, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access
Programmed cell death-related prognostic genes mediate dysregulation of the immune microenvironment in triple-negative breast cancer
Xiaowen Ma, Hui Shan, Chen Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
LSTM-MGTO: a novel early breast cancer detection using long short term memory based modified gorilla troops optimization algorithm
Duraiswamy Umamaheswari, M. K. Jayanthi Kannan, I. Priya Stella Mary, et al.
Network Modeling Analysis in Health Informatics and Bioinformatics (2025) Vol. 14, Iss. 1
Closed Access
CircRNAs: a novel potential strategy to treat breast cancer
Pangzhou Chen, Jinhui Zhang, Song Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The role of ferroptosis in breast cancer: tumor progression, immune microenvironment interactions and therapeutic interventions
Yiping Wang, Chuanyun Tang, Keqin Wang, et al.
European Journal of Pharmacology (2025) Vol. 996, pp. 177561-177561
Closed Access
Histone acetylation modulators in breast cancer
Xueying Yuan, Jeffrey M. Rosen
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top